Security key
29446K106
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 4,173,854
- Total 13F value
- $14,111,189
- Share change
- -122,109
- SEC-reported price per share
- $3.38
- Number of holders
- 19
- Value change
- -$864,475
- Number of buys
- 10
- Number of sells
- 5
- Shares outstanding
- 66,704,586
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2019
Institutions
19
Top holders
10
EQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2020
Previous quarter: Q3 2019
Equillium, Inc. SEC filings
Equillium, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29446K106
Recent filing periods:
Ownership snapshot
Top reported holders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VICTORY CAPITAL MANAGEMEN...
Disclosed value leader
VICTORY CAPITAL MANAGEMEN...
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 3.1%
Showing 1-6 of 15 holder rows.
Quick read
VICTORY CAPITAL MANAGEMENT INC leads the comparable SEC ownership view at 3.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VICTORY CAPITAL MANAGEMENT INC's linked filing trail.
Comparable ownership
Top 5
VICTORY CAPITAL MANAGEMENT INC
3.1%
PFM Health Sciences, LP
1.6%
FMR LLC
0.93%
VANGUARD GROUP INC
0.42%
Alyeska Investment Group, L.P.
0.21%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VICTORY CAPITAL MANAGEMENT INC |
13F
Company
|
3.1%
|
$7,863,000
2,069,233 shares
|
— | 30 Sep 2019 |
| PFM Health Sciences, LP |
13F
Company
|
1.6%
|
$4,047,000
1,064,979 shares
|
— | 30 Sep 2019 |
| FMR LLC |
13F
Company
|
0.93%
|
$2,355,000
619,843 shares
|
— | 30 Sep 2019 |
| VANGUARD GROUP INC |
13F
Company
|
0.42%
|
$1,062,000
279,329 shares
|
— | 30 Sep 2019 |
| Alyeska Investment Group, L.P. |
13F
Company
|
0.21%
|
$537,000
141,260 shares
|
— | 30 Sep 2019 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.08%
|
$207,000
54,502 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
4,173,854
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
17
Q4 2019 holders
19
Holder diff
2
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend